SUBSCRIBE
SUBSCRIBE

IntelGenx Corp. Announces Commercial Launch of Forfivo XL™ in USA

October 9, 2012 | 
1 min read

SAINT LAURENT, Quebec, Oct. 9, 2012 (GLOBE NEWSWIRE) -- IntelGenx Corp. (TSX-V:IGX) (OTCQX:IGXT) (“IntelGenx”, “the Company”) today announced that Forfivo XL™ is now available by prescription in the USA.